PURE Bioscience (PURE) Short Interest Ratio & Short Volume $0.09 +0.01 (+11.84%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest PURE Bioscience Short Interest DataPURE Bioscience (PURE) has a short interest of 400 shares. This marks a -97.24% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 32,910 shares to cover all short positions.Current Short Interest400 sharesPrevious Short Interest14,500 sharesChange Vs. Previous Month-97.24%Dollar Volume Sold Short$36.00Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares111,856,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume53,042 sharesAverage Trading Volume32,910 sharesToday's Volume Vs. Average161% Short Selling PURE Bioscience? Sign up to receive the latest short interest report for PURE Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPURE Short Interest Over TimePURE Days to Cover Over TimePURE Percentage of Float Shorted Over Time Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> PURE Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024400 shares $36.00 -97.2%N/A0 $0.09 11/15/202414,500 shares $2,283.75 -68.9%N/A0.2 $0.16 10/31/202446,600 shares $4,380.40 +50.8%N/A0.9 $0.09 10/15/202430,900 shares $2,070.30 -47.2%N/A1.3 $0.07 9/30/202458,500 shares $4,446.00 +181.3%N/A0.9 $0.08 9/15/202420,800 shares $1,664.00 -30.7%N/A0.5 $0.08 Get the Latest News and Ratings for PURE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter. 8/31/202430,000 shares $1,890.00 -61.2%N/A0.6 $0.06 8/15/202477,300 shares $4,808.06 -18.7%N/A4.9 $0.06 7/31/202495,100 shares $7,588.98 +397.9%N/A1.5 $0.08 7/15/202419,100 shares $1,254.87 No ChangeN/A1 $0.07 6/30/202419,100 shares $1,184.20 No ChangeN/A0.5 $0.06 6/15/202419,100 shares $1,241.50 -48.8%N/A0.2 $0.07 5/31/202437,300 shares $2,816.15 +532.2%N/A1 $0.08 5/15/20245,900 shares $526.87 -1.7%N/A0.2 $0.09 4/30/20246,000 shares $426.00 +122.2%N/A0.1 $0.07 4/15/20242,700 shares $206.82 +575.0%N/A0 $0.08 3/31/2024400 shares $39.60 No ChangeN/A0 $0.10 3/15/2024400 shares $36.00 -97.7%N/A0 $0.09 2/29/202417,200 shares $1,886.84 -37.9%N/A1 $0.11 2/15/202427,700 shares $2,963.90 +3,362.5%N/A0.3 $0.11 1/15/20241,700 shares $213.01 +325.0%N/A0 $0.13 12/31/2023400 shares $51.86 -97.2%N/A0 $0.13 12/15/202314,300 shares $2,145.00 +2,760.0%N/A0.1 $0.15 11/30/2023500 shares $59.00 -44.4%N/A0 $0.12 11/15/2023900 shares $92.97 +125.0%N/A0 $0.10 10/31/2023400 shares $32.40 No ChangeN/A0 $0.08 10/15/2023400 shares $47.20 -94.0%N/A0 $0.12 9/30/20236,700 shares $743.70 -10.7%N/A0.1 $0.11 9/15/20237,500 shares $757.50 -61.9%N/A0.1 $0.10 8/31/202319,700 shares $2,068.50 -36.9%N/A0.4 $0.11 8/15/202331,200 shares $3,744.00 +766.7%N/A0.6 $0.12 7/31/20233,600 shares $306.00 -25.0%N/A0.4 $0.09 7/15/20234,800 shares $528.00 +500.0%N/A0.1 $0.11 6/30/2023800 shares $63.92 +100.0%N/A0 $0.08 6/15/2023400 shares $35.85 No ChangeN/A0 $0.09 5/31/2023400 shares $44.40 -93.1%N/A0 $0.11 5/15/20235,800 shares $640.90 -55.0%N/A0.2 $0.11 4/30/202312,900 shares $1,161.00 +101.6%N/A0.1 $0.09 4/15/20236,400 shares $640.00 -14.7%N/A0 $0.10 3/31/20237,500 shares $1,148.06 +368.8%N/A0.1 $0.152025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. 3/15/20231,600 shares $228.32 -90.0%N/A0 $0.14 2/28/202316,000 shares $2,160.00 +3,900.0%N/A0.3 $0.14 2/15/2023400 shares $56.00 -96.2%N/A0 $0.14 1/31/202310,600 shares $1,375.88 +715.4%N/A0.3 $0.13 1/15/20231,300 shares $130.00 +225.0%N/A0 $0.10 12/30/2022400 shares $33.92 -93.8%N/A0 $0.08 12/15/20226,400 shares $851.84 -65.6%N/A0.1 $0.13 11/30/202218,600 shares $2,788.14 +463.6%N/A0.1 $0.15 11/15/20223,300 shares $561.50 -88.5%N/A0.1 $0.17 10/31/202228,600 shares $4,807.66 +5.9%N/A0.3 $0.17 10/15/202227,000 shares $5,211.00 +23.9%N/A1.9 $0.19 9/30/202221,800 shares $4,360.00 +1.4%N/A0.2 $0.20 9/15/202221,500 shares $4,942.85 -40.9%N/A0 $0.23 8/31/202236,400 shares $7,280.00 +23.0%N/A0.2 $0.20 8/15/202229,600 shares $6,808.00 -1.3%N/A0.2 $0.23 7/31/202230,000 shares $5,991.00 +226.1%N/A0.1 $0.20 7/15/20229,200 shares $1,835.40 -72.0%N/A0.2 $0.20 6/30/202232,900 shares $6,251.00 -23.3%N/A0.7 $0.19 6/15/202242,900 shares $8,258.25 -3.2%N/A1.7 $0.19 5/31/202244,300 shares $8,860.00 +23.7%N/A0.9 $0.20 5/15/202235,800 shares $6,798.42 +1,093.3%N/A0.7 $0.19 4/30/20223,000 shares $524.40 -67.4%N/A0.1 $0.17 4/15/20229,200 shares $1,768.70 -75.7%N/A0.1 $0.19 3/31/202237,800 shares $7,182.00 +1,045.5%N/A0.3 $0.19 3/15/20223,300 shares $595.65 -83.8%N/A0.1 $0.18 2/28/202220,400 shares $3,967.80 +100.0%N/A1.4 $0.19 2/15/202210,200 shares $2,036.94 +108.2%N/A0.1 $0.20 1/31/20224,900 shares $1,078.00 +2.1%N/A0.1 $0.22 1/15/20224,800 shares $962.40 +50.0%N/A0 $0.20 12/31/20213,200 shares $610.24 -93.9%N/A0 $0.19 12/15/202152,300 shares $14,293.59 +325.2%N/A0.4 $0.27 11/30/202112,300 shares $4,059.00 +200.0%N/A0.1 $0.33 11/15/20214,100 shares $1,314.05 -70.1%N/A0 $0.32 10/29/202113,700 shares $5,206.00 +291.4%N/A0.2 $0.38 10/15/20213,500 shares $1,174.25 -7.9%N/A0.1 $0.34 9/30/20213,800 shares $1,487.70 -86.9%N/A0.1 $0.39 9/15/202129,100 shares $12,236.55 +419.6%N/A0.2 $0.42 8/31/20215,600 shares $2,024.68 -11.1%N/A0 $0.36 8/13/20216,300 shares $2,387.07 +152.0%N/A0.2 $0.38 7/30/20212,500 shares $1,050.00 No ChangeN/A0.1 $0.42 7/15/20212,500 shares $1,102.75 -30.6%N/A0.1 $0.44 6/30/20213,600 shares $1,638.00 +28.6%N/A0 $0.46 6/15/20212,800 shares $1,343.44 -6.7%N/A0.1 $0.48 5/28/20213,000 shares $1,530.00 +25.0%N/A0 $0.51 5/14/20212,400 shares $1,488.00 No ChangeN/A0 $0.62 4/30/20212,400 shares $1,488.00 +50.0%N/A0.1 $0.62 4/15/20211,600 shares $1,120.00 No ChangeN/A0 $0.70 3/31/20211,600 shares $1,160.00 -63.6%N/A0 $0.73 3/15/20214,400 shares $3,124.00 +7.3%N/A0 $0.71 2/26/20214,100 shares $3,198.00 -46.8%N/A0.1 $0.782025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. 2/12/20217,700 shares $6,006.00 +57.1%N/A0.1 $0.78 1/29/20214,900 shares $3,724.00 -71.8%N/A0.1 $0.76 1/15/202111,600 shares $9,628.00 -4.1%N/A0.1 $0.83 12/31/202023,500 shares $21,150.00 +102.6%N/A0.1 $0.90 12/15/202011,600 shares $10,556.00 -4.1%N/A0.1 $0.91 11/30/202012,100 shares $12,826.00 +26.0%N/A0.2 $1.06 11/15/20209,600 shares $12,480.00 +5.5%N/A0.1 $1.30 10/30/20209,100 shares $12,103.00 -15.0%N/A0.2 $1.33 10/15/202010,700 shares $14,980.00 -60.8%N/A0.1 $1.40 9/30/202027,300 shares $46,655.70 +58.7%N/A0.3 $1.71 9/15/202017,200 shares $25,800.00 -45.4%N/A0.2 $1.50 8/31/202031,500 shares $47,250.00 -15.3%N/A0.4 $1.50 8/14/202037,200 shares $56,544.00 +4.2%N/A0.4 $1.52 7/31/202035,700 shares $51,051.00 +21.4%N/A0.2 $1.43 7/15/202029,400 shares $39,249.00 -45.5%N/A0.1 $1.34 6/30/202053,900 shares $98,906.50 -44.9%N/A0.1 $1.84 6/15/202097,800 shares $187,776.00 +45.1%N/A0.2 $1.92 5/29/202067,400 shares $82,902.00 +140.7%N/A0.2 $1.23 5/15/202028,000 shares $22,120.00 +147.8%N/A0.1 $0.79 4/30/202011,300 shares $6,836.50 -13.7%N/A0.1 $0.61 4/15/202013,100 shares $7,922.88 -47.4%N/A0.1 $0.60 3/31/202024,900 shares $15,936.00 +3,012.5%N/A0 $0.64 3/13/2020800 shares $480.00 -94.7%N/A0 $0.60 2/28/202015,200 shares $10,944.00 +19.7%N/A0.1 $0.72 2/14/202012,700 shares $6,858.00 +1,714.3%N/A0.1 $0.54 1/31/2020700 shares $336.00 +75.0%N/A0 $0.48 1/15/2020400 shares $188.00 No ChangeN/A0 $0.47 12/31/2019400 shares $152.00 No ChangeN/A0 $0.38 PURE Short Interest - Frequently Asked Questions What is PURE Bioscience's current short interest? Short interest is the volume of PURE Bioscience shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 400 shares of PURE short. Learn More on PURE Bioscience's current short interest. Is PURE Bioscience's short interest increasing or decreasing? PURE Bioscience saw a decline in short interest during the month of November. As of November 30th, there was short interest totaling 400 shares, a decline of 97.2% from the previous total of 14,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does PURE Bioscience's short interest compare to its competitors? Here is how the short interest of companies in the industry of "chemicals" compare to PURE Bioscience: Evogene Ltd. (1.55%), Gulf Resources, Inc. (0.48%), SUIC Worldwide Holdings Ltd. (0.00%), SenesTech, Inc. (4.76%), N2OFF, Inc. (1.09%), CN Energy Group. Inc. (0.05%), Methes Energies International Ltd. (0.01%), Mace Security International, Inc. (0.02%), American Environmental Partners, Inc. (0.00%), Tantech Holdings Ltd (9.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short PURE Bioscience stock? Short selling PURE is an investing strategy that aims to generate trading profit from PURE Bioscience as its price is falling. PURE shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PURE Bioscience? A short squeeze for PURE Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PURE, which in turn drives the price of the stock up even further. How often is PURE Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PURE, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies EVGN Short Squeeze GURE Short Squeeze SUIC Short Squeeze SNES Short Squeeze NITO Short Squeeze CNEY Short Squeeze MEIL Short Squeeze MACE Short Squeeze AEPT Short Squeeze TANH Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PURE) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PURE Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PURE Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PURE Stock Alerts